Abstract
The anti-tumour mechanisms following Bacillus Calmette-Guérin (BCG) treatment of bladder-cancer remain largely unknown. Previous studies have shown involvement of nitric-oxide (NO) formation in the BCG-mediated effect. We analyzed the effects of macrophage secreted factors (MSFs) from BCG-stimulated RAW264.7 cells on the bladder-cancer cell line MBT2. Direct treatment with BCG did not induce NO in MBT2-cells whereas supernatant from BCG-stimulated macrophages increased NOS2 mRNA and protein expression, NO concentrations and cell-death. Blocking NO-synthesis with the NOS-inhibitor L-NAME did not affect levels of cell-death suggesting cytotoxic pathways involving other signalling molecules than NO. Several such candidate genes were identified in a microarray.
Keywords:
Bacillus Calmette-Guérin; Cytokines; Nitric oxide; Nitric oxide synthase; Urinary bladder cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / therapeutic use*
-
BCG Vaccine / therapeutic use*
-
Cell Death / drug effects
-
Cell Line, Tumor
-
Culture Media, Conditioned / metabolism
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Profiling / methods
-
Humans
-
Macrophages / drug effects*
-
Macrophages / immunology
-
Macrophages / metabolism
-
Mice
-
Nitric Oxide / metabolism*
-
Nitric Oxide Synthase Type II / antagonists & inhibitors
-
Nitric Oxide Synthase Type II / genetics
-
Nitric Oxide Synthase Type II / metabolism
-
Oligonucleotide Array Sequence Analysis
-
Paracrine Communication / drug effects*
-
RNA, Messenger / metabolism
-
Signal Transduction / drug effects
-
Treatment Outcome
-
Up-Regulation
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / genetics
-
Urinary Bladder Neoplasms / immunology
-
Urinary Bladder Neoplasms / metabolism
-
Urinary Bladder Neoplasms / pathology
Substances
-
Antineoplastic Agents
-
BCG Vaccine
-
Culture Media, Conditioned
-
Enzyme Inhibitors
-
RNA, Messenger
-
Nitric Oxide
-
NOS2 protein, human
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse